TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2951793

Group type: EXPERIMENTAL
Intervention: Fenoterol (100, 200, 400, 800, 1600 micrograms)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40, 80, 160, 320, 640 micrograms)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Duovent (100 micrograms fenoterol + 40 micrograms ipratropium bromide)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combination of fenoterol and ipratropium bromide (Duovent)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 9
Study: 29298506

Group type: EXPERIMENTAL
Intervention: Removal of the stapes head only (Group 2b)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Removal of the entire stapes superstructure (Group 1b)
Number of subjects: 145
Study: 27485469

Group type: EXPERIMENTAL
Intervention: 4-week maximal-intensity isometric training of the right first dorsal interosseus muscle through key pinching
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study: 24894416

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: No treatment (non-SSRIs)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 65
Study: 22245692

Group type: EXPERIMENTAL
Intervention: Individual counselling group (every six weeks) + optional series of 25 group seminars (every week)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group seminars only
Number of subjects: 48
Study: 20606431

Group type: EXPERIMENTAL
Intervention: Duraphat 5,000 ppm F
Number of subjects: 211

Group type: COMPARATOR
Intervention: Pepsodent Superfluor 1,450 ppm F
Number of subjects: 211
Study: 17651380

Group type: EXPERIMENTAL
Intervention: Active ASIT with Alternaria alternata extract
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 16580957

Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with FDG uptake of 50% or greater
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with wall thickening (WT) of 10% or greater
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Gated FDG-PET with WT of 10% or greater
Number of subjects: 38

Group type: COMPARATOR
Intervention: Magnetic resonance imaging before and 6 months after revascularization
Number of subjects: 38
Study: 14557006

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Regular insulin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (non-diabetic pregnant women)
Number of subjects: 49
Study: 10881265

Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratio (MTR)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mean diffusivity (D) histogram peak heights
Number of subjects: 21
Study: 8822674

Group type: EXPERIMENTAL
Intervention: Wheelchair users
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nondisabled individuals
Number of subjects: 8
Study: 1460149

Group type: EXPERIMENTAL
Intervention: Various forms of treatment for depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Specific types of personality disorders
Number of subjects: 0
Study: 6376207

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/triamterene 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg
Number of subjects: 0
Study: 31444995

Group type: EXPERIMENTAL
Intervention: Genetically determined longer telomere length
Number of subjects: 261837
Study: 29374734

Group type: EXPERIMENTAL
Intervention: 5×4Gy
Number of subjects: 203

Group type: COMPARATOR
Intervention: 10×3Gy
Number of subjects: 203
Study: 26443018

Group type: EXPERIMENTAL
Intervention: Air stacking via home ventilator
Number of subjects: 52

Group type: COMPARATOR
Intervention: Air stacking via resuscitator bag
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both methods (home ventilator and resuscitator bag)
Number of subjects: 52
Study: 24212255

Group type: EXPERIMENTAL
Intervention: Lokomat(®) experimental gait training (LE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lokomat(®) conventional gait training (LC)
Number of subjects: 26
Study: 22173953

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study: 19906829

Group type: EXPERIMENTAL
Intervention: Web-based early intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 18072061

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI) with magnification
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Magnifying Chromoendoscopy
Number of subjects: 99
Study: 15661601

Group type: EXPERIMENTAL
Intervention: Internet one-item mode
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Internet mode
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Internet multiple items per screen format
Number of subjects: 591

Group type: COMPARATOR
Intervention: Paper and pencil (P&P) mode
Number of subjects: 591
Study: 11854728

Group type: EXPERIMENTAL
Intervention: Spliced vein bypass grafting
Number of subjects: 36

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene grafting with a distal vein cuff
Number of subjects: 36
Study: 10395628

Group type: EXPERIMENTAL
Intervention: Live-culture yogurt (200 g/d for 1 year)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pasteurized yogurt (200 g/d for 1 year)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (no yogurt)
Number of subjects: 3
Study: 7550527

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP; ‐15 mmHg) after glucose ingestion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP; ‐15 mmHg) in the postabsorptive state
Number of subjects: 8
Study: 2160356

Group type: EXPERIMENTAL
Intervention: Clinical score
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Plasma parathyroid hormone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Discriminant function based on parathyroid hormone and alkaline phosphatase
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Discriminant function utilizing calcium, phosphate and alkaline phosphatase
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Plasma 25-hydroxy-vitamin D
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Clinical score with abnormal results
Number of subjects: 160
Study: 6941657

Group type: EXPERIMENTAL
Intervention: Change in lifestyle (increased physical activity, decreased fat and salt intake)
Number of subjects: 928

Group type: COMPARATOR
Intervention: Control group (no lifestyle change)
Number of subjects: 928
Study: 29880065

Group type: EXPERIMENTAL
Intervention: Supportive Counseling (SC)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Coping and Communication (CCI)
Number of subjects: 246
Study: 27914670

Group type: EXPERIMENTAL
Intervention: Corega denture adhesive
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Fittydent denture adhesive
Number of subjects: 34

Group type: COMPARATOR
Intervention: No denture adhesive
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dentate control group
Number of subjects: 34
Study: 25369827

Group type: EXPERIMENTAL
Intervention: Probiotic (5 × 10(9) CFUs; twice daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24524339

Group type: EXPERIMENTAL
Intervention: Cladribine
Number of subjects: 223

Group type: COMPARATOR
Intervention: Fludarabine
Number of subjects: 223

Group type: COMPARATOR
Intervention: Chlorambucil
Number of subjects: 223
Study: 22901562

Group type: EXPERIMENTAL
Intervention: Resveratrol (250 mg/d) along with oral hypoglycemic agents
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral hypoglycemic agents only
Number of subjects: 62
Study: 19968378

Group type: EXPERIMENTAL
Intervention: Family cognitive-behavioral preventive intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Self-study written information condition (Control)
Number of subjects: 111
Study: 17675054

Group type: EXPERIMENTAL
Intervention: Levosimendan (10-minute bolus 12 microg/kg, followed by 0.1 microg/kg/min for 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no levosimendan)
Number of subjects: 40
Study: 15146566

Group type: COMPARATOR
Intervention: CBE (Control arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBE supplemented with mammography (Study arm)
Number of subjects: 0
Study: 11328262

Group type: EXPERIMENTAL
Intervention: Aspirin (400 mg b.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (400 mg b.d.) + Vitamin C (480 mg b.d.)
Number of subjects: 0
Study: 9877109

Group type: EXPERIMENTAL
Intervention: Calcium infusion rate varied to produce a fall of at least 0.2 mmol/l in ionized calcium during hemodialysis.
Number of subjects: 2

Group type: COMPARATOR
Intervention: Calcium infusion rate maintained stable ionized calcium during hemodialysis.
Number of subjects: 2
Study: 8033617

Group type: EXPERIMENTAL
Intervention: PCR-based method for detecting HPV DNA
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: ABC method for detecting HPV-Ag
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Microscopy for detecting koilocytes
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Electron microscopy for detecting HPV particles
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Follow-up observation for 3 months to 2 years
Number of subjects: 616
Study: 2916485

Group type: EXPERIMENTAL
Intervention: High-protein diet (HPD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Low-protein diet (LPD)
Number of subjects: 5
Study: 172181

Group type: EXPERIMENTAL
Intervention: Equine ('natural') oestrogens for three months followed by placebo for three months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for three months followed by equine ('natural') oestrogens for three months
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Equine ('natural') oestrogens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Natural oestrogen administration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Synthetic oestrogen administration with oral contraception
Number of subjects: 30
Study: 31519668

Group type: EXPERIMENTAL
Intervention: Conscious Sedation (CS)
Number of subjects: 270

Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 270
Study: 28395750

Group type: EXPERIMENTAL
Intervention: Selamectin plus sarolaner (Stronghold® Plus, Zoetis)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Imidacloprid plus moxidectin (Advocate® for Cats, Bayer)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Fipronil (Frontline® Spot on, Merial)
Number of subjects: 277
Study: 25761850

Group type: EXPERIMENTAL
Intervention: Simulation training (4 one-on-one, 15-minute sessions over 4 months)
Number of subjects: 29
Study: 23388004

Group type: EXPERIMENTAL
Intervention: 15% paromomycin-0.5% gentamicin
Number of subjects: 375
Study: 21656715

Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic perforator surgery (SEPS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saphenous surgery alone
Number of subjects: 75
Study: 19168107

Group type: EXPERIMENTAL
Intervention: DNA vaccine (intramuscularly or intradermally)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Towne only)
Number of subjects: 0
Study: 16505513

Group type: EXPERIMENTAL
Intervention: 10-s maximal cycling sprint
Number of subjects: 7

Group type: COMPARATOR
Intervention: Rest (control trial)
Number of subjects: 7
Study: 15285057

Group type: EXPERIMENTAL
Intervention: 100 ml of Iohexol 300
Number of subjects: 100

Group type: COMPARATOR
Intervention: 75 ml of Ioversol 320
Number of subjects: 100
Study: 11227031

Group type: EXPERIMENTAL
Intervention: Potato dumplings (165g)
Number of subjects: 17

Group type: COMPARATOR
Intervention: White bread (90g)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pizza (equivalent carbohydrate amount)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hard toasted bread (equivalent carbohydrate amount)
Number of subjects: 17
Study: 9630829

Group type: EXPERIMENTAL
Intervention: OPC‐31260 (30 mg, orally)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy subjects (n=6)
Number of subjects: 8
Study: 7946238

Group type: EXPERIMENTAL
Intervention: Family intervention (experimental group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Regular use of medication with family intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 78
Study: 2438755

Group type: EXPERIMENTAL
Intervention: Complete transurethral adenomectomy of the prostate
Number of subjects: 167

Group type: COMPARATOR
Intervention: Less extensive resection
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Preoperative urethral instrumentation
Number of subjects: 167
Study: 29686759

Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional simulation debriefing
Number of subjects: 38
Study: 29932590

Group type: EXPERIMENTAL
Intervention: Phase I intervention (14 classes, 60 minutes each, starting during pregnancy)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Phase II intervention (3 monthly classes, 60 minutes each, postpartum)
Number of subjects: 100
Study: 25495754

Group type: EXPERIMENTAL
Intervention: Fresh-squeezed orange juice (FOJ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially processed orange juice (POJ)
Number of subjects: 0
Study: 22795420

Group type: EXPERIMENTAL
Intervention: Chest compressions performed on the floor
Number of subjects: 74

Group type: COMPARATOR
Intervention: Chest compressions performed on a stretcher
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Participants trained within a year performing on the floor
Number of subjects: 74

Group type: COMPARATOR
Intervention: Participants trained within a year performing on a stretcher
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Participants trained over a year ago performing on the floor
Number of subjects: 74

Group type: COMPARATOR
Intervention: Participants trained over a year ago performing on a stretcher
Number of subjects: 74
Study: 20026575

Group type: EXPERIMENTAL
Intervention: Adjustment group intervention (six, 2-hour group treatment sessions)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 40
Study: 18656721

Group type: EXPERIMENTAL
Intervention: Sialodochoplasty (n = 28)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No sialodochoplasty (n = 26)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Successful stone removal
Number of subjects: 59
Study: 16402638

Group type: EXPERIMENTAL
Intervention: Diseased sinus
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control sinus
Number of subjects: 49
Study: 12810245

Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone (30 mg/day) plus metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone (15 or 30 mg/day) plus sulfonylurea
Number of subjects: 0
Study: 11080699

Group type: EXPERIMENTAL
Intervention: Avoidance of indoor allergens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical and chemical measures targeting house dust mite, pet, and cockroach allergens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education of allergic patients
Number of subjects: 0
Study: 9148020

Group type: EXPERIMENTAL
Intervention: Detection of anti-neutrophil cytoplasmic antibodies (ANCA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: C-ANCA pattern
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: P-ANCA pattern
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Identification of actin as a target antigen
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Absorption of sera with actin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Western Blot analysis with actin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Actin-ELISA
Number of subjects: 32
Study: 8342184

Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (ASA) 75 mg/d for 6 months
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 232
Study: 3538957

Group type: EXPERIMENTAL
Intervention: Monitored group (theophylline dosages adjusted daily based on estimated clearance)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Monitored group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (dosages determined by attending physicians)
Number of subjects: 91
Study: 31581836

Group type: EXPERIMENTAL
Intervention: Shorter message
Number of subjects: 6896

Group type: EXPERIMENTAL
Intervention: Longer message
Number of subjects: 6896

Group type: EXPERIMENTAL
Intervention: Overall recruitment through patient portal messages
Number of subjects: 6896
Study: 29170266

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control
Number of subjects: 206
Study: 27462118

Group type: EXPERIMENTAL
Intervention: Intravenous albumin 25% at 2 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 24766978

Group type: EXPERIMENTAL
Intervention: Ezetimibe prescriptions in the US
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Ezetimibe prescriptions in Canada
Number of subjects: 100000
Study: 24365167

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4 plus lactated Ringer's solution
Number of subjects: 48

Group type: COMPARATOR
Intervention: lactated Ringer's solution
Number of subjects: 48
Study: 21340381

Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA) - 25 grams total infused during surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (saline solution)
Number of subjects: 42
Study: 18180340

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (400 mg/d)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 16822122

Group type: EXPERIMENTAL
Intervention: Task confusion errors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Error detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posterror processes implying error correction response
Number of subjects: 0
Study: 12608556

Group type: EXPERIMENTAL
Intervention: Blood flow at 200 ml/min
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Blood flow at 250 ml/min
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Blood flow at 300 ml/min
Number of subjects: 13
Study: 11299576

Group type: EXPERIMENTAL
Intervention: Alternating pressure air mattress A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternating pressure air mattress B
Number of subjects: 0
Study: 8635384

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (cisplatin 50 mg/m2 or 100 mg/m2 plus 3 g/m2 ifosfamide and 6 mg/m2 mitomycin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Knowledge of genetic alterations
Number of subjects: 0
Study: 30652260

Group type: EXPERIMENTAL
Intervention: Off-label topical therapies (e.g., prostaglandin analogs, polyphenols like latanoprost and procyanidin oligomers)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Procyanidin oligomers
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 28722284

Group type: EXPERIMENTAL
Intervention: Visiglide 2 guidewire (group V)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional guidewire (group C)
Number of subjects: 100
Study: 26684457

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib sodium 1 mg·kg(‐1) (Group P, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Group S, n = 30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib sodium 1 mg·kg(‐1) (Group P)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 60
Study: 25238838

Group type: EXPERIMENTAL
Intervention: Home-based treadmill training (16-week program, 3 sessions/week, 30-40 min treadmill exercise at 60-75% peak heart rate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 60
Study: 22186009

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1 g)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Morphine (0.1 mg/kg)
Number of subjects: 73
Study: 18974283

Group type: EXPERIMENTAL
Intervention: Teduglutide 50 mg/mL and 20 mg/mL formulations
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Teduglutide 50 mg/mL formulation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Teduglutide 20 mg/mL formulation (1.0 mL)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Teduglutide treatments
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Injection site pain
Number of subjects: 64
Study: 16988133

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (20,000 IU for <12 months; 45,000 IU for >=12 months) every 2 months
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation in children infected with enteropathogenic Escherichia coli (EPEC)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation in children not infected with Ascaris lumbricoides
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 12802915

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control
Number of subjects: 101
Study: 10866887

Group type: EXPERIMENTAL
Intervention: Remifentanil at 1.0 microg/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.33 microg/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.2 microg/kg/min
Number of subjects: 8
Study: 15622781

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (without CsA)
Number of subjects: 100
Study: 8225624

Group type: EXPERIMENTAL
Intervention: Piperacillin (2 g)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid (2.2 g)
Number of subjects: 595
Study: 3535004

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ranitidine (R)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Non-responders (NR)
Number of subjects: 38